Download PDF
Planta Med 2013; 79(05): 313-321
DOI: 10.1055/s-0032-1328211
Biological and Pharmacological Activity
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Neuroprotection of a Novel Synthetic Caffeic Acid-Syringic Acid Hybrid Compound against Experimentally Induced Transient Cerebral Ischemic Damage

In Hye Kim   *
1   Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, South Korea
,
Bing Chun Yan   *
1   Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, South Korea
,
Joon Ha Park
1   Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, South Korea
,
Go Heum Yeun
2   Department of Chemical and Biological Engineering, Hanbat National University, Daejeon, South Korea
,
Yongbae Yim
2   Department of Chemical and Biological Engineering, Hanbat National University, Daejeon, South Korea
,
Ji Hyeon Ahn
3   Laboratory of Neuroscience, Department of Physical Therapy, College of Rehabilitation Science, Daegu University, Gyeongsan, South Korea
,
Jae-Chul Lee
1   Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, South Korea
,
In Koo Hwang
4   Department of Anatomy and Cell Biology, College of Veterinary Medicine, and Research Institute for Veterinary Science, Seoul National University, Seoul, South Korea
,
Jun Hwi Cho
5   Department of Emergency Medicine and Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon, South Korea
6   Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon, South Korea
,
Young-Myeong Kim
7   Vascular System Research Center and Department of Molecular and Cellular Biochemistry, School of Medicine, Kangwon National University, Chuncheon, South Korea
,
Yun Lyul Lee
8   Department of Physiology and Institute of Neurodegeneration and Neuroregeneration, College of Medicine, Hallym University, Chuncheon, South Korea
,
Jeong Ho Park
2   Department of Chemical and Biological Engineering, Hanbat National University, Daejeon, South Korea
,
Moo-Ho Won
1   Department of Neurobiology, School of Medicine, Kangwon National University, Chuncheon, South Korea
6   Institute of Medical Sciences, Kangwon National University Hospital, School of Medicine, Kangwon National University, Chuncheon, South Korea
› Author Affiliations
Further Information

Publication History

received 22 July 2012
revised 15 January 2013

accepted 16 January 2013

Publication Date:
14 February 2013 (online)

    Permissions and Reprints

Abstract

We investigated effects of caffeic acid, syringic acid, and their synthesis on transient cerebral ischemic damage in the gerbil hippocampal CA1 region. In the 10 mg/kg caffeic acid-, syringic acid-, and 20 mg/kg syringic-treated ischemia groups, we did not find any significant neuroprotection in the ischemic hippocampal CA region. In the 20 mg/kg caffeic acid- and 10 mg/kg caffeic acid-syringic acid-treated ischemia groups, moderate neuroprotection was found in the hippocampal CA1 region. In the 20 mg/kg caffeic acid-syringic acid-treated ischemia group, a strong neuroprotective effect was found in the ischemic hippocampal CA1 region: about 89 % of hippocampal CA1 region pyramidal neurons survived. We also observed changes in glial cells (astrocytes and microglia) in the ischemic hippocampal CA1 region in all the groups. Among them, the distribution pattern of the glial cells was only in the 20 mg/kg caffeic acid-syringic acid-treated ischemia group similar to that in the sham group (control). In brief, 20 mg/kg caffeic acid-syringic acid showed a strong neuroprotective effect with an inhibition of glia activation in the hippocampal CA1 region induced by transient cerebral ischemia.

Key words

natural phenolic compounds - ischemic stroke - neuroprotection - hippocampus

* In Hye Kim and Bing Chun Yan contributed equally to this study.


 

  • References

  • 1 Kirino T. Delayed neuronal death in the gerbil hippocampus following ischemia. Brain Res 1982; 239: 57-69
    CrossrefPubMedGoogle Scholar
  • 2 Schmidt-Kastner R, Freund TF. Selective vulnerability of the hippocampus in brain ischemia. Neuroscience 1991; 40: 599-636
    CrossrefPubMedGoogle Scholar
  • 3 Lin CS, Polsky K, Nadler JV, Crain BJ. Selective neocortical and thalamic cell death in the gerbil after transient ischemia. Neuroscience 1990; 35: 289-299
    CrossrefPubMedGoogle Scholar
  • 4 Xu D, Du W, Zhao L, Davey AK, Wang J. The neuroprotective effects of isosteviol against focal cerebral ischemia injury induced by middle cerebral artery occlusion in rats. Planta Med 2008; 74: 816-821
    Article in Thieme ConnectPubMedGoogle Scholar
  • 5 Yao Y, Han DD, Zhang T, Yang Z. Quercetin improves cognitive deficits in rats with chronic cerebral ischemia and inhibits voltage-dependent sodium channels in hippocampal CA1 pyramidal neurons. Phytother Res 2010; 24: 136-140
    CrossrefPubMedGoogle Scholar
  • 6 Zhang HF, Hu XM, Wang LX, Xu SQ, Zeng FD. Protective effects of scutellarin against cerebral ischemia in rats: evidence for inhibition of the apoptosis-inducing factor pathway. Planta Med 2009; 75: 121-126
    Article in Thieme ConnectPubMedGoogle Scholar
  • 7 Nichiforesco E, Coucou V. [On the distribution of o-dihydroxyphenols of the caffeic acid type in the artichoke leaf and on their variation as a function of temperature]. Ann Pharm Fr 1966; 24: 127-132
    PubMedGoogle Scholar
  • 8 Sondheimer E. On the distribution of caffeic acid and the chlorogenic acid isomers in plants. Arch Biochem Biophys 1958; 74: 131-138
    CrossrefPubMedGoogle Scholar
  • 9 Ohtsuki T, Matsumoto M, Hayashi Y, Yamamoto K, Kitagawa K, Ogawa S, Yamamoto S, Kamada T. Reperfusion induces 5-lipoxygenase translocation and leukotriene C4 production in ischemic brain. Am J Physiol 1995; 268: H1249-H1257
    PubMedGoogle Scholar
  • 10 Yang JQ, Zhou QX, Liu BZ, He BC. Protection of mouse brain from aluminum-induced damage by caffeic acid. CNS Neurosci Ther 2008; 14: 10-16
    CrossrefPubMedGoogle Scholar
  • 11 Koshihara Y, Neichi T, Murota S, Lao A, Fujimoto Y, Tatsuno T. Caffeic acid is a selective inhibitor for leukotriene biosynthesis. Biochim Biophys Acta 1984; 792: 92-97
    CrossrefPubMedGoogle Scholar
  • 12 Mehrotra A, Shanbhag R, Chamallamudi MR, Singh VP, Mudgal J. Ameliorative effect of caffeic acid against inflammatory pain in rodents. Eur J Pharmacol 2011; 666: 80-86
    CrossrefPubMedGoogle Scholar
  • 13 Irmak MK, Fadillioglu E, Sogut S, Erdogan H, Gulec M, Ozer M, Yagmurca M, Gozukara ME. Effects of caffeic acid phenethyl ester and alpha-tocopherol on reperfusion injury in rat brain. Cell Biochem Funct 2003; 21: 283-289
    CrossrefPubMedGoogle Scholar
  • 14 Vieira O, Laranjinha J, Madeira V, Almeida L. Cholesteryl ester hydroperoxide formation in myoglobin-catalyzed low density lipoprotein oxidation: concerted antioxidant activity of caffeic and p-coumaric acids with ascorbate. Biochem Pharmacol 1998; 55: 333-340
    CrossrefPubMedGoogle Scholar
  • 15 Hirota A, Taki S, Kawaii S, Yano M, Abe N. 1, 1-Diphenyl-2-picrylhydrazyl radical-scavenging compounds from soybean miso and antiproliferative activity of isoflavones from soybean miso toward the cancer cell lines. Biosci Biotechnol Biochem 2000; 64: 1038-1040
    CrossrefPubMedGoogle Scholar
  • 16 Kampa M, Alexaki VI, Notas G, Nifli AP, Nistikaki A, Hatzoglou A, Bakogeorgou E, Kouimtzoglou E, Blekas G, Boskou D, Gravanis A, Castanas E. Antiproliferative and apoptotic effects of selective phenolic acids on T47D human breast cancer cells: potential mechanisms of action. Breast Cancer Res 2004; 6: R63-R74
    CrossrefPubMedGoogle Scholar
  • 17 Ramachandran V, Raja B. Protective effects of syringic acid against acetaminophen-induced hepatic damage in albino rats. J Basic Clin Physiol Pharmacol 2010; 21: 369-385
    PubMedGoogle Scholar
  • 18 Zhou Y, Fang SH, Ye YL, Chu LS, Zhang WP, Wang ML, Wei EQ. Caffeic acid ameliorates early and delayed brain injuries after focal cerebral ischemia in rats. Acta Pharmacol Sin 2006; 27: 1103-1110
    CrossrefPubMedGoogle Scholar
  • 19 Seo JY, Lee CH, Cho JH, Choi JH, Yoo KY, Kim DW, Park OK, Li H, Choi SY, Hwang IK, Won MH. Neuroprotection of ebselen against ischemia/reperfusion injury involves GABA shunt enzymes. J Neurol Sci 2009; 285: 88-94
    CrossrefPubMedGoogle Scholar
  • 20 Yoo KY, Li H, Hwang IK, Choi JH, Lee CH, Kwon DY, Ryu SY, Kim YS, Kang IJ, Shin HC, Won MH. Zizyphus attenuates ischemic damage in the gerbil hippocampus via its antioxidant effect. J Med Food 2010; 13: 557-563
    CrossrefPubMedGoogle Scholar
  • 21 Yu JT, Lee CH, Yoo KY, Choi JH, Li H, Park OK, Yan B, Hwang IK, Kwon YG, Kim YM, Won MH. Maintenance of anti-inflammatory cytokines and reduction of glial activation in the ischemic hippocampal CA1 region preconditioned with lipopolysaccharide. J Neurol Sci 2010; 296: 69-78
    CrossrefPubMedGoogle Scholar
  • 22 Hwang IK, Yoo KY, Li H, Park OK, Lee CH, Choi JH, Jeong YG, Lee YL, Kim YM, Kwon YG, Won MH. Indole-3-propionic acid attenuates neuronal damage and oxidative stress in the ischemic hippocampus. J Neurosci Res 2009; 87: 2126-2137
    CrossrefPubMedGoogle Scholar
  • 23 Schmued LC, Hopkins KJ. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res 2000; 874: 123-130
    CrossrefPubMedGoogle Scholar
  • 24 Loskota WJ, Lomax P, Verity MA. A stereotaxic atlas of the Mongolian gerbil brain (Meriones unguiculatus). Ann Arbor: Ann Arbor Science; 1974
    CrossrefGoogle Scholar
  • 25 Wei X, Zhao L, Ma Z, Holtzman DM, Yan C, Dodel RC, Hampel H, Oertel W, Farlow MR, Du Y. Caffeic acid phenethyl ester prevents neonatal hypoxic-ischaemic brain injury. Brain 2004; 127: 2629-2635
    CrossrefPubMedGoogle Scholar
  • 26 Wang SX, Guo H, Hu LM, Liu YN, Wang YF, Kang LY, Gao XM. Caffeic acid ester fraction from Erigeron breviscapus inhibits microglial activation and provides neuroprotection. Chin J Integr Med 2012; 18: 437-444
    CrossrefPubMedGoogle Scholar
  • 27 Jeong CH, Jeong HR, Choi GN, Kim DO, Lee U, Heo HJ. Neuroprotective and anti-oxidant effects of caffeic acid isolated from Erigeron annuus leaf. Chin Med 2011; 6: 25
    CrossrefPubMedGoogle Scholar
  • 28 Gulcin I. Antioxidant activity of caffeic acid (3,4-dihydroxycinnamic acid). Toxicology 2006; 217: 213-220
    CrossrefPubMedGoogle Scholar
  • 29 Kalkan Yildirim H, Delen Akcay Y, Guvenc U, Yildirim Sozmen E. Protection capacity against low-density lipoprotein oxidation and antioxidant potential of some organic and non-organic wines. Int J Food Sci Nutr 2004; 55: 351-362
    CrossrefPubMedGoogle Scholar
  • 30 Chao CC, Molitor TW, Hu S. Neuroprotective role of IL-4 against activated microglia. J Immunol 1993; 151: 1473-1481
    PubMedGoogle Scholar
  • 31 Floyd RA. Antioxidants, oxidative stress, and degenerative neurological disorders. Proc Soc Exp Biol Med 1999; 222: 236-245
    CrossrefPubMedGoogle Scholar
  • 32 Fujimura M, Tominaga T, Chan PH. Neuroprotective effect of an antioxidant in ischemic brain injury: involvement of neuronal apoptosis. Neurocrit Care 2005; 2: 59-66
    CrossrefPubMedGoogle Scholar
  • 33 Zhang J, Li B, Liu J, Wang X, Wang Y, Li Y, Luo W. Synthesis of caffeic acid derivatives and their targeting on brain. Acta Academiae Medicinae Militaris Tertiae 2010; 03: 234-237
    PubMedGoogle Scholar
  • 34 Zhao J, Pati S, Redell JB, Zhang M, Moore AN, Dash PK. Caffeic acid phenethyl ester protects blood-brain barrier integrity and reduces contusion volume in rodent models of traumatic brain injury. J Neurotrauma 2012; 29: 1209-1218
    CrossrefPubMedGoogle Scholar
  • 35 Ordy JM, Wengenack TM, Bialobok P, Coleman PD, Rodier P, Baggs RB, Dunlap WP, Kates B. Selective vulnerability and early progression of hippocampal CA1 pyramidal cell degeneration and GFAP-positive astrocyte reactivity in the rat four-vessel occlusion model of transient global ischemia. Exp Neurol 1993; 119: 128-139
    CrossrefPubMedGoogle Scholar
  • 36 Petito CK, Halaby IA. Relationship between ischemia and ischemic neuronal necrosis to astrocyte expression of glial fibrillary acidic protein. Int J Dev Neurosci 1993; 11: 239-247
    CrossrefPubMedGoogle Scholar
  • 37 Steward O, Torre ER, Tomasulo R, Lothman E. Seizures and the regulation of astroglial gene expression. Epilepsy Res Suppl 1992; 7: 197-209
    PubMedGoogle Scholar
  • 38 Stoll G, Jander S, Schroeter M. Inflammation and glial responses in ischemic brain lesions. Prog Neurobiol 1998; 56: 149-171
    CrossrefPubMedGoogle Scholar
  • 39 Park JH, Joo HS, Yoo KY, Shin BN, Kim IH, Lee CH, Choi JH, Byun K, Lee B, Lim SS, Kim MJ, Won MH. Extract from Terminalia chebula seeds protect against experimental ischemic neuronal damage via maintaining SODs and BDNF levels. Neurochem Res 2011; 36: 2043-2050
    CrossrefPubMedGoogle Scholar
  • 40 Hailer NP, Jarhult JD, Nitsch R. Resting microglial cells in vitro: analysis of morphology and adhesion molecule expression in organotypic hippocampal slice cultures. Glia 1996; 18: 319-331
    CrossrefPubMedGoogle Scholar
  • 41 Schwartz M, Butovsky O, Bruck W, Hanisch UK. Microglial phenotype: is the commitment reversible?. Trends Neurosci 2006; 29: 68-74
    CrossrefPubMedGoogle Scholar
  • 42 Hwang IK, Yoo KY, Kim DW, Choi SY, Kang TC, Kim YS, Won MH. Ionized calcium-binding adapter molecule 1 immunoreactive cells change in the gerbil hippocampal CA1 region after ischemia/reperfusion. Neurochem Res 2006; 31: 957-965
    CrossrefPubMedGoogle Scholar
  • 43 Yrjanheikki J, Keinanen R, Pellikka M, Hokfelt T, Koistinaho J. Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci U S A 1998; 95: 15769-15774
    CrossrefPubMedGoogle Scholar
  • 44 Woo YJ, Lee BH, Yeun GH, Kim HJ, Won MH, Kim SH, Lee BH, Park JH. Selective butyrylcholinesterase inhibitors using polyphenol-polyphenol hybrid molecules. Bull Korean Chem Soc 2011; 8: 2593
    PubMedGoogle Scholar
  • 45 Yamasaki Y, Matsuura N, Shozuhara H, Onodera H, Itoyama Y, Kogure K. Interleukin-1 as a pathogenetic mediator of ischemic brain damage in rats. Stroke 1995; 26: 676-680 discussion 681
    CrossrefPubMedGoogle Scholar